Terns Pharmaceuticals, Inc. (TERN)
46.46
+0.38
(+0.84%)
USD |
NASDAQ |
Mar 17, 16:00
47.30
+0.84
(+1.82%)
After-Hours: 20:00
Terns Pharmaceuticals Total Liabilities (Quarterly) : 17.58M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 190.22M |
| Insmed, Inc. | 1.526B |
| Ligand Pharmaceuticals, Inc. | 543.42M |
| ADMA Biologics, Inc. | 156.03M |
| Cogent Biosciences, Inc. | 301.24M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 301.65M |
| Shareholders Equity (Quarterly) | 284.07M |
| Debt to Equity Ratio | 0.0036 |
| Current Ratio | 19.52 |
| Net Debt Paydown Yield | -0.02% |